- Home
- Companies
- Imbed Biosciences
- Products
- Microlyte - Surgical Wound Management
Microlyte - Surgical Wound Management
Microbial contamination is a threat to healing of all surgical wounds. Learn more about how Microlyte Surgical can assist in the protection of surgical sites. Microlyte® Surgical provides you with a new antimicrobial tool for management of surgical wounds. Created for surgeons – by surgeons. The world’s first and only fully-synthetic, antimicrobial, and bioresorbable matrix Microbial contamination is a threat to healing of all surgical wounds. Microlyte® Surgical contains bacteria-killing antimicrobial silver. Reduction of bacterial bioburden may reduce microbial colonization and risks of wound infection. This addition of ionic and metallic silver provides rapid, effective, and sustained antimicrobial activity.
Microlyte® Surgical absorbs wound fluid and transforms into a bioresorbable material that intimately contours to the underlying surgical wound. It maintains a physiologically moist microenvironment. In vitro and in vivo, studies indicate that components of the matrix allow cell growth and neovascularization. 1,2,3
There are roughly 5,000 hospital in the US doing a total of 30 million surgical procedures each year. This translates to an average of 6,000 surgeries per hospital per year.6
Across all specialties, surgical site infections (SSI) occur at a 2.6% rate. The typical SSI results in an additional 7-10 day hospital stay and a cost of treat as high as $30,000, which is not reimbursed by Medicare.
SSIs represent a significant cost to your hospital and health system.
- Average SSI Rate: 2.6% (780,000 SSIs/30 million procedures)7
- Number of SSIs: 6,000 at 2.6% = 156
- Average Cost Per SSI: $30,0007,8
